STAGE III PANCREATIC NEUROENDOCRINE TUMOR AJCC V8
Clinical trials for STAGE III PANCREATIC NEUROENDOCRINE TUMOR AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III PANCREATIC NEUROENDOCRINE TUMOR AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III PANCREATIC NEUROENDOCRINE TUMOR AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets Hard-to-Treat pancreatic tumors
Disease control Recruiting nowThis early-phase trial is testing whether combining two targeted therapies—sunitinib malate and Lutathera—is safe for people with advanced pancreatic neuroendocrine tumors that have spread or cannot be removed. Sunitinib blocks signals that help tumors grow, while Lutathera deliv…
Matched conditions: STAGE III PANCREATIC NEUROENDOCRINE TUMOR AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could chemo after surgery keep pancreatic cancer at bay?
Disease control Recruiting nowThis study looks at whether giving two chemotherapy drugs (capecitabine and temozolomide) after surgery can prevent or delay the return of high-risk pancreatic neuroendocrine tumors. About 141 people who have had their tumor removed will be randomly assigned to receive the drugs …
Matched conditions: STAGE III PANCREATIC NEUROENDOCRINE TUMOR AJCC V8
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC